Each of these sites provides a safe and effective way to administer the medication, but understanding how to choose the best spot for you is key to a comfortable experience
A clinical study of a GLP-1 RA highlighted that participants who followed dietary advice and injected weekly saw an average 18% lower energy intake compared to placebo, with significant reductions in body weight and cardio-metabolic risk
Multiple clinicians have noted that the appetite suppression from GLP-1 medications effectively manages steroid-induced hunger in a way that willpower alone cannot
Second, most available trials are characterized by short follow-up periods (generally 612 months), providing limited insight into the durability of weight loss, muscle preservation, or cardiometabolic benefits after treatment cessation
This news comes after results of several other oral GLP-1 therapies were released
Data represented as the mean SEM